|
Hancock® II Aortic and Mitral Bioprostheses
 Designed for Performance Over Time
Surgeons who wish to provide the best option in terms of durability for their stented tissue valve patients can feel confident with the clinical history of the Hancock® II bioprosthesis.
Freedom from Primary Tissue Failure at 15 Years:
AVR and MVR
Results from David and colleagues have supported the excellent long-term performance in all age groups and in aortic, mitral and double valve applications.
David reports 100% freedom from primary tissue failure at 15 years for aortic valve patients and 89% for mitral valve patients in age 65 and above.
 |
Download a PDF of "Durability of the Hancock® II Tissue Valve in Patients 65 Years and Older" |
For more information on Hancock® II bioprosthesis durability select one of the studies below.
|
